{"id":12271,"date":"2026-11-03T18:14:01","date_gmt":"2026-11-03T17:14:01","guid":{"rendered":"https:\/\/mumak.me\/?p=12271"},"modified":"2026-11-03T19:26:32","modified_gmt":"2026-11-03T18:26:32","slug":"eli-lilly-q3-2026-earnings-update","status":"publish","type":"post","link":"https:\/\/mumak.me\/en\/portfolio-updates\/company-update\/eli-lilly-q3-2026-earnings-update\/","title":{"rendered":"Eli Lilly \u2013 Q3 2026 Earnings Update"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"12271\" class=\"elementor elementor-12271 elementor-12270\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e1ac738 e-flex e-con-boxed e-con e-parent\" data-id=\"e1ac738\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b8e9f5a elementor-widget elementor-widget-text-editor\" data-id=\"b8e9f5a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p data-pm-slice=\"1 1 []\"><strong>Eli Lilly<\/strong> published its third-quarter results on October 29, 2026. The pharmaceutical group posted strong revenue growth, driven by international demand for diabetes and obesity medicines. The stock responded with a sharp price increase.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e410360 elementor-widget elementor-widget-gn_tradingview_chart\" data-id=\"e410360\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"gn_tradingview_chart.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t        <div class=\"gn-tv-widget gn-tv-widget--chart\" style=\"--gn-tv-height: 450px; --gn-tv-min-height: 450px;\" data-gn-tv-type=\"symbol-overview\" data-gn-tv-config=\"{&quot;lineWidth&quot;:2,&quot;lineType&quot;:0,&quot;chartType&quot;:&quot;area&quot;,&quot;showVolume&quot;:true,&quot;fontColor&quot;:&quot;rgb(106, 109, 120)&quot;,&quot;gridLineColor&quot;:&quot;rgba(46, 46, 46, 0.06)&quot;,&quot;volumeUpColor&quot;:&quot;rgba(34, 171, 148, 0.5)&quot;,&quot;volumeDownColor&quot;:&quot;rgba(247, 82, 95, 0.5)&quot;,&quot;backgroundColor&quot;:&quot;#ffffff&quot;,&quot;widgetFontColor&quot;:&quot;rgba(69, 56, 42, 1)&quot;,&quot;upColor&quot;:&quot;#22ab94&quot;,&quot;downColor&quot;:&quot;#f7525f&quot;,&quot;borderUpColor&quot;:&quot;#22ab94&quot;,&quot;borderDownColor&quot;:&quot;#f7525f&quot;,&quot;wickUpColor&quot;:&quot;#22ab94&quot;,&quot;wickDownColor&quot;:&quot;#f7525f&quot;,&quot;colorTheme&quot;:&quot;light&quot;,&quot;isTransparent&quot;:false,&quot;locale&quot;:&quot;en&quot;,&quot;chartOnly&quot;:false,&quot;scalePosition&quot;:&quot;right&quot;,&quot;scaleMode&quot;:&quot;Normal&quot;,&quot;fontFamily&quot;:&quot;Inter, -apple-system, BlinkMacSystemFont, Trebuchet MS, Roboto, Ubuntu, sans-serif&quot;,&quot;valuesTracking&quot;:&quot;1&quot;,&quot;changeMode&quot;:&quot;price-and-percent&quot;,&quot;symbols&quot;:[[&quot;NYSE:LLY|12M&quot;]],&quot;dateRanges&quot;:[&quot;1d|1&quot;,&quot;1m|30&quot;,&quot;3m|60&quot;,&quot;12m|1D&quot;,&quot;60m|1W&quot;,&quot;all|1M&quot;],&quot;fontSize&quot;:&quot;10&quot;,&quot;headerFontSize&quot;:&quot;medium&quot;,&quot;autosize&quot;:true,&quot;width&quot;:&quot;100%&quot;,&quot;height&quot;:&quot;100%&quot;,&quot;noTimeScale&quot;:false,&quot;hideDateRanges&quot;:false,&quot;showMA&quot;:false,&quot;maLength&quot;:9,&quot;maLineColor&quot;:&quot;#2962FF&quot;,&quot;maLineWidth&quot;:1,&quot;hideMarketStatus&quot;:false,&quot;hideSymbolLogo&quot;:false}\">\n            <div class=\"gn-tv-widget__inner\">\n                <div class=\"gn-tv-widget__embed gn-tv-widget__chart\">\n                    <div class=\"tradingview-widget-container__widget\"><\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n        \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-9a58f06 e-flex e-con-boxed e-con e-parent\" data-id=\"9a58f06\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f904adb elementor-widget elementor-widget-html\" data-id=\"f904adb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t\n<style>\/* MUMAK Finanzkennzahlen *\/\n.mumak-financial {\n  --navy: #29485A;\n  --gold: #C89B50;\n  --cream: #FAF7F2;\n  --line: #E5E7E8;\n  font-family: inherit;\n  color: var(--navy);\n  max-width: 100%;\n  margin: 28px 0;\n}\n\n.mumak-financial * {\n  box-sizing: border-box;\n}\n\n.mumak-financial .mf-header {\n  border-left: 4px solid var(--gold);\n  padding-left: 17px;\n  margin-bottom: 22px;\n}\n\n.mumak-financial .mf-eyebrow {\n  color: var(--gold);\n  font-size: 11px;\n  font-weight: 700;\n  letter-spacing: 1.5px;\n  text-transform: uppercase;\n  margin-bottom: 7px;\n}\n\n.mumak-financial .mf-title {\n  font-size: clamp(21px, 3vw, 28px);\n  line-height: 1.25;\n  font-weight: 700;\n  color: var(--navy);\n  margin: 0 0 7px;\n}\n\n.mumak-financial .mf-subtitle {\n  font-size: 13px;\n  color: #697780;\n  margin: 0;\n}\n\n.mumak-financial .mf-kpis {\n  display: grid;\n  grid-template-columns: repeat(4, minmax(0, 1fr));\n  gap: 12px;\n  margin-bottom: 25px;\n}\n\n.mumak-financial .mf-kpi {\n  background: var(--cream);\n  border: 1px solid #EAE4DB;\n  border-radius: 9px;\n  padding: 18px 13px;\n  min-width: 0;\n}\n\n.mumak-financial .mf-value {\n  display: block;\n  font-size: clamp(19px, 2.3vw, 27px);\n  font-weight: 700;\n  color: var(--navy);\n  line-height: 1.2;\n  margin-bottom: 9px;\n  font-variant-numeric: tabular-nums;\n}\n\n.mumak-financial .mf-label {\n  display: block;\n  font-size: 12px;\n  font-weight: 600;\n  line-height: 1.4;\n}\n\n.mumak-financial .mf-detail {\n  display: block;\n  margin-top: 7px;\n  font-size: 11px;\n  color: #7A858A;\n}\n\n.mumak-financial .mf-section-title {\n  font-size: 18px;\n  font-weight: 700;\n  color: var(--navy);\n  margin: 0 0 13px;\n}\n\n.mumak-financial .mf-table-wrap {\n  width: 100%;\n  overflow-x: auto;\n  border: 1px solid var(--line);\n  border-radius: 9px;\n  margin-bottom: 24px;\n}\n\n.mumak-financial table {\n  width: 100%;\n  min-width: 470px;\n  border-collapse: collapse;\n  border: 0;\n  margin: 0;\n  font-size: 13px;\n  background: #FFFFFF;\n}\n\n.mumak-financial table thead th {\n  background: var(--navy);\n  color: #FFFFFF;\n  font-size: 11px;\n  letter-spacing: .5px;\n  text-transform: uppercase;\n  padding: 14px 15px;\n  border: 0;\n}\n\n.mumak-financial table th:first-child,\n.mumak-financial table td:first-child {\n  text-align: left;\n  width: 52%;\n}\n\n.mumak-financial table th:not(:first-child),\n.mumak-financial table td:not(:first-child) {\n  text-align: right;\n}\n\n.mumak-financial table tbody td {\n  padding: 13px 15px;\n  border: 0;\n  border-bottom: 1px solid var(--line);\n  vertical-align: middle;\n  font-variant-numeric: tabular-nums;\n}\n\n.mumak-financial table tbody tr:nth-child(even) {\n  background: #FAFAF9;\n}\n\n.mumak-financial table tbody tr:last-child td {\n  border-bottom: 0;\n}\n\n.mumak-financial .mf-amount {\n  font-weight: 600;\n}\n\n.mumak-financial .mf-outlook {\n  background: var(--cream);\n  border: 1px solid #EAE4DB;\n  border-left: 4px solid var(--gold);\n  border-radius: 8px;\n  padding: 22px;\n  margin-top: 8px;\n}\n\n.mumak-financial .mf-outlook-title {\n  font-size: 18px;\n  font-weight: 700;\n  margin: 0 0 18px;\n}\n\n.mumak-financial .mf-forecast {\n  display: grid;\n  grid-template-columns: repeat(2, minmax(0, 1fr));\n  gap: 18px;\n}\n\n.mumak-financial .mf-forecast-label {\n  display: block;\n  font-size: 12px;\n  color: #66747D;\n  margin-bottom: 7px;\n}\n\n.mumak-financial .mf-forecast-value {\n  display: block;\n  font-size: clamp(17px, 2.4vw, 23px);\n  font-weight: 700;\n  line-height: 1.3;\n  overflow-wrap: anywhere;\n}\n\n.mumak-financial .mf-source {\n  margin-top: 15px;\n  font-size: 11px;\n  line-height: 1.6;\n  color: #758087;\n}\n\n\/* Mobile Darstellung *\/\n@media (max-width: 767px) {\n  .mumak-financial .mf-kpis {\n    grid-template-columns: repeat(2, minmax(0, 1fr));\n    gap: 9px;\n  }\n\n  .mumak-financial .mf-kpi {\n    padding: 15px 11px;\n  }\n\n  .mumak-financial .mf-forecast {\n    grid-template-columns: 1fr;\n    gap: 17px;\n  }\n\n  .mumak-financial .mf-outlook {\n    padding: 18px 15px;\n  }\n\n  .mumak-financial table {\n    font-size: 12px;\n  }\n}\n<\/style><section class=\"mumak-financial\" lang=\"de\" aria-label=\"Eli Lilly Finanzkennzahlen Q3 2026\"><!-- \u00dcBERSCHRIFT --><div class=\"mf-header\"><div class=\"mf-eyebrow\">Finanzergebnisse<\/div><h2 class=\"mf-title\">Q3 2026 im \u00dcberblick\n    <\/h2><p class=\"mf-subtitle\">Eli Lilly | Drittes Quartal 2026\n    <\/p><\/div><!-- WICHTIGSTE KENNZAHLEN --><div class=\"mf-kpis\"><div class=\"mf-kpi\"><span class=\"mf-value\">24,40 Mrd. USD<\/span><span class=\"mf-label\">Gesamtumsatz<\/span><span class=\"mf-detail\" style=\"color: #27845B; font-weight: 600;\">+39 % zum Vorjahr\n<\/span><\/div><div class=\"mf-kpi\"><span class=\"mf-value\">10,72 Mrd. USD<\/span><span class=\"mf-label\">Mounjaro-Umsatz<\/span><span class=\"mf-detail\" style=\"color: #27845B; font-weight: 600;\">+65 % zum Vorjahr\n<\/span><\/div><div class=\"mf-kpi\"><span class=\"mf-value\">6,45 Mrd. USD<\/span><span class=\"mf-label\">Nettogewinn (GAAP)\n      <\/span><span class=\"mf-detail\" style=\"color: #27845B; font-weight: 600;\">+16 % zum Vorjahr\n<\/span><\/div><div class=\"mf-kpi\"><span class=\"mf-value\">7,48 USD<\/span><span class=\"mf-label\">Bereinigtes Ergebnis je Aktie\n      <\/span><span class=\"mf-detail\" style=\"color: #27845B; font-weight: 600;\">+7 % zum Vorjahr\n<\/span><\/span><\/div><\/div><!-- FINANZTABELLE --><h3 class=\"mf-section-title\">Finanzkennzahlen im Detail\n  <\/h3><div class=\"mf-table-wrap\" role=\"region\" aria-label=\"Tabelle der Finanzkennzahlen\" tabindex=\"0\"><table><thead><tr><th scope=\"col\">Kennzahl<\/th><th scope=\"col\">Q3 2026<\/th><th scope=\"col\">Ver\u00e4nderung zum Vorjahr<\/th><\/tr><\/thead><tbody><tr><td>Umsatz USA<\/td><td class=\"mf-amount\">15,1 Mrd. USD<\/td><td style=\"text-align:right; color:#27845B;\">+34 %<\/td><\/tr><tr><td>Umsatz au\u00dferhalb der USA<\/td><td class=\"mf-amount\">9,3 Mrd. USD<\/td><td style=\"text-align:right; color:#27845B;\">+47 %<\/td><\/tr><tr><td>Mounjaro-Umsatz<\/td><td class=\"mf-amount\">10,72 Mrd. USD<\/td><td style=\"text-align:right; color:#27845B;\">+65 %<\/td><\/tr><tr><td>Zepbound-Umsatz<\/td><td class=\"mf-amount\">5,35 Mrd. USD<\/td><td style=\"text-align:right; color:#27845B;\"><strong>+49 %<\/strong><\/td><\/tr><tr><td>Bruttogewinn\n          <\/td><td class=\"mf-amount\">20,46 Mrd. USD<\/td><td style=\"text-align:right; color:#27845B;\">+40 %<\/td><\/tr><tr><td>Bruttomarge\n          <\/td><td class=\"mf-amount\">83,9 %<\/td><td style=\"text-align:right; color:#27845B;\"><strong>+1,0 Prozentpunkt<\/strong><\/td><\/tr><tr><td>Forschungs- und Entwicklungsausgaben<\/td><td class=\"mf-amount\">4,25 Mrd. USD<\/td><td style=\"text-align:right; color:#27845B;\">+23 %<\/td><\/tr><tr><td>Nettogewinn (GAAP)\n          <\/td><td style=\"text-align:right;\"><strong>6,45 Mrd. USD<\/strong><\/td><td style=\"text-align:right; color:#27845B;\"><strong>+16 %<\/strong><\/td><\/tr><tr><td>Bereinigter Nettogewinn (Non-GAAP)\n          <\/td><td class=\"mf-amount\">6,68 Mrd. USD<\/td><td style=\"text-align:right; color:#27845B;\"><strong>+6 %<\/strong><\/td><\/tr><tr><td>Verw\u00e4ssertes Ergebnis je Aktie (GAAP)<\/td><td class=\"mf-amount\">7,22 USD<\/td><td style=\"text-align:right; color:#27845B;\"><strong>+16 %<\/strong><\/td><tr><td>Bereinigtes Ergebnis je Aktie\n          <\/td><td class=\"mf-amount\">7,48 USD<\/td><td style=\"text-align:right; color:#27845B;\"><strong>+7 %<\/strong><\/td><\/tr><\/tbody><\/table><\/div><!-- QUELLENANGABE --><p class=\"mf-source\">Quelle: Eli Lilly,\n    Quartalsbericht Q3 2026.\n  <\/p><\/section>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5888df6 elementor-widget elementor-widget-text-editor\" data-id=\"5888df6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3 data-pm-slice=\"1 1 []\">Mounjaro and Zepbound drive growth<\/h3><p>Quarterly revenue rose 39% to $24.40 billion. <strong>Mounjaro<\/strong> in particular delivered strong momentum, with revenue up 65% to $10.72 billion. <strong>Zepbound<\/strong> generated $5.35 billion, up 49%.<\/p><p>Net income increased 16% to $6.45 billion. Adjusted earnings per share came in at $7.48 (+7%). At the same time, Eli Lilly invested $4.25 billion in research and development.<\/p><h3>Chart Analysis: Upward momentum after the quarterly results<\/h3><p>On the release date, October 29, the stock rose 6.63% to $1,373.70. At the open of $1,332.73, the price was already well above the prior close of $1,288.30.<\/p><p>The positive gap up suggests an immediate reassessment of the results by the market. On October 30, the upward momentum continued with a closing price of $1,417.54. <\/p><h3>Significance for the UMBRELLA Strategy<\/h3><p><strong>Eli Lilly<\/strong> remains a key representative of the healthcare sector within the <strong>UMBRELLA Strategy<\/strong>. Growth in Mounjaro and Zepbound, as well as progress in drug development, support the operational outlook.<\/p><p>At the same time, the high importance of individual products, the development of drug prices, and the stock&#8217;s valuation remain key factors for further assessment.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4e31745 e-con-full e-flex e-con e-child\" data-id=\"4e31745\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8d6e245 elementor-widget elementor-widget-text-editor\" data-id=\"8d6e245\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p data-pm-slice=\"1 1 []\"><span style=\"color: #003366;\"><span style=\"color: #b58a2a;\"><strong>Key takeaway: <\/strong><\/span><\/span><strong>Eli Lilly<\/strong> increases quarterly revenue by 39%, driven by strong demand for Mounjaro and Zepbound. The raised full-year guidance and positive share-price reaction underscore the pharmaceutical group\u2019s operational growth momentum.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Eli Lilly reports 39% revenue growth in the third quarter of 2026. Strong demand for Mounjaro and Zepbound is driving a positive share-price reaction.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[151],"tags":[315,327],"aktie":[],"class_list":["post-12271","post","type-post","status-publish","format-standard","hentry","category-company-update","tag-eli-lilly","tag-pharmaindustrie"],"acf":[],"_links":{"self":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/12271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/comments?post=12271"}],"version-history":[{"count":5,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/12271\/revisions"}],"predecessor-version":[{"id":12292,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/12271\/revisions\/12292"}],"wp:attachment":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/media?parent=12271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/categories?post=12271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/tags?post=12271"},{"taxonomy":"aktie","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/aktie?post=12271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}